Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 2 (2005), Issue 11 (November)

1. Impaired breast cancer resistance protein mediated drug transport in plasma cells in multiple myeloma.
   Leuk Res, 29(12): 1455-8. [Abstract] [Full-text]
2. Results of a phase 1 clinical trial of thalidomide in combination with fludarabine as initial therapy for patients with treatment-requiring chronic lymphocytic leukemia (CLL).
   Blood, 106(10): 3348-52. [Abstract] [Full-text]
3. Urate oxidation during percutaneous transluminal coronary angioplasty and thrombolysis in patients with coronary artery disease.
   Clin Chim Acta, 362(1): 131-7. [Abstract] [Full-text]
4. Influence of estradiol on micturition thresholds in the rat: involvement of the hypogastric nerve.
   Am J Physiol Regul Integr Comp Physiol, 289(6): R1724-8. [Abstract] [Full-text]
5. Is hemoglobin in hemoglobin vesicles infused for isovolemic hemodilution necessary to improve oxygenation in critically ischemic hamster skin?
   Am J Physiol Heart Circ Physiol, 289(6): H2624-31. [Abstract] [Full-text]
6. Predicting fluid responsiveness in patients undergoing cardiac surgery: functional haemodynamic parameters including the Respiratory Systolic Variation Test and static preload indicators.
   Br J Anaesth, 95(6): 746-55. [Abstract] [Full-text]
7. Adjuvant chemotherapy for breast cancer--"one fits all"?
   Breast, 14(6): 564-9. [Abstract] [Full-text]
8. Preoperative (neoadjuvant) systemic treatment of breast cancer.
   Breast, 14(6): 576-81. [Abstract] [Full-text]
9. Adjuvant chemotherapy in 2005: standards and beyond.
   Breast, 14(6): 439-45. [Abstract] [Full-text]
10. The best use of adjuvant chemotherapy: new drugs and new use of "old" drugs.
    Breast, 14(6): 570-5. [Abstract] [Full-text]
11. Theoretical studies of Alzheimer's disease drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine (GTS-21) and its derivatives.
    Biochem Biophys Res Commun, 338(2): 1059-64. [Abstract] [Full-text]
12. Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group.
    J Clin Oncol, 23(33): 8380-8. [Abstract] [Full-text]
13. Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trial.
    J Clin Oncol, 23(33): 8371-9. [Abstract] [Full-text]
14. Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.
    J Clin Oncol, 23(33): 8340-7. [Abstract] [Full-text]
15. Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer.
    J Clin Oncol, 23(33): 8331-9. [Abstract] [Full-text]
16. Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01.
    J Clin Oncol, 23(33): 8322-30. [Abstract] [Full-text]
17. Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for high-risk, node-negative breast cancer: treatment results of Intergroup Protocol INT-0102.
    J Clin Oncol, 23(33): 8313-21. [Abstract] [Full-text]
18. Treatment of symptomatic simple renal cysts by percutaneous aspiration and ethanol sclerotherapy.
    BJU Int, 96(9): 1369-72. [Abstract] [Full-text]
19. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
    J Clin Oncol, 23(33): 8289-95. [Abstract] [Full-text]
20. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
    J Clin Oncol, 23(33): 8477-82. [Abstract] [Full-text]
21. New treatment options have changed the survival of patients with follicular lymphoma.
    J Clin Oncol, 23(33): 8447-52. [Abstract] [Full-text]
22. Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck.
    Br J Plast Surg, 58(8): 1073-8. [Abstract] [Full-text]
23. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
    Blood, 106(12): 3725-32. [Abstract] [Full-text]
24. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.
    Blood, 106(12): 3760-7. [Abstract] [Full-text]
25. High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.
    Blood, 106(12): 3755-9. [Abstract] [Full-text]
26. Should primary angioplasty be available for all patients with an ST elevation myocardial infarction?
    Heart, 91(12): 1509-11. [Abstract] [Full-text]
27. Cytogenetic damage in lymphocytes of patients undergoing therapy for small cell lung cancer and ovarian carcinoma.
    Toxicol Appl Pharmacol, 209(2): 183-91. [Abstract] [Full-text]
28. Tension pneumothorax complicating autologous "blood patch" pleurodesis.
    Thorax, 60(12): 1066-7. [Abstract] [Full-text]
29. Comparison between normal saline and a polyelectrolyte solution for fluid resuscitation in severely dehydrated infants with acute diarrhoea.
    Ann Trop Paediatr, 25(4): 253-60. [Abstract] [Full-text]
30. Body water and plasma volume in severe community-acquired pneumonia: implications for fluid therapy.
    Ann Trop Paediatr, 25(4): 243-52. [Abstract] [Full-text]
31. Treatment of stage IV(A-B) nasopharyngeal carcinoma by induction-concurrent chemoradiotherapy and accelerated fractionation.
    Int J Radiat Oncol Biol Phys, 63(5): 1331-8. [Abstract] [Full-text]
32. Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.
    Int J Radiat Oncol Biol Phys, 63(5): 1325-30. [Abstract] [Full-text]
33. The future development of bevacizumab in colorectal cancer.
    Oncology, 69: 34-45. [Abstract] [Full-text]
34. Managing patients treated with bevacizumab combination therapy.
    Oncology, 69: 25-33. [Abstract] [Full-text]
35. Bevacizumab combined with standard fluoropyrimidine-based chemotherapy regimens to treat colorectal cancer.
    Oncology, 69: 17-24. [Abstract] [Full-text]
36. Early colloid replacement therapy in a near-fatal model of hemorrhagic shock.
    Anesth Analg, 101(6): 1785-91. [Abstract] [Full-text]
37. Managing medication in schools.
    Arch Dis Child, 90(12): 1253-5. [Abstract] [Full-text]
38. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials.
    Leukemia, 19(12): 2130-8. [Abstract] [Full-text]
39. Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials.
    Leukemia, 19(12): 2090-100. [Abstract] [Full-text]
40. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials.
    Leukemia, 19(12): 2030-42. [Abstract] [Full-text]
41. Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.
    Leukemia, 19(12): 2125-9. [Abstract] [Full-text]
42. Enhancement of brain distribution of anticancer agents using DeltaG, the 12 kDa active fragment of ZOT.
    Int J Pharm, 306(1): 122-31. [Abstract] [Full-text]
43. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Int J Pharm, 306(1): 71-82. [Abstract] [Full-text]
44. Transfollicular drug delivery--is it a reality?
    Int J Pharm, 306(1): 1-14. [Abstract] [Full-text]
45. Formulation design of a novel fast-disintegrating tablet.
    Int J Pharm, 306(1): 83-90. [Abstract] [Full-text]
46. Simultaneous effects of tocopheryl polyethylene glycol succinate (TPGS) on local hair growth promotion and systemic absorption of topically applied minoxidil in a mouse model.
    Int J Pharm, 306(1): 91-8. [Abstract] [Full-text]
47. Microfabricated drug delivery devices.
    Int J Pharm, 306(1): 15-23. [Abstract] [Full-text]
48. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin.
    Int J Pharm, 306(1): 142-9. [Abstract] [Full-text]
49. Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891.
    Leukemia, 19(12): 2054-62. [Abstract] [Full-text]
50. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
    Leukemia, 19(12): 2101-16. [Abstract] [Full-text]
51. Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report.
    Leukemia, 19(12): 2072-81. [Abstract] [Full-text]
52. Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group.
    Leukemia, 19(12): 2082-9. [Abstract] [Full-text]
53. Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols.
    Leukemia, 19(12): 2043-53. [Abstract] [Full-text]
54. Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials.
    Leukemia, 19(12): 2063-71. [Abstract] [Full-text]
55. Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia.
    Leukemia, 19(12): 2117-24. [Abstract] [Full-text]
56. Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours.
    Cancer Chemother Pharmacol, 57(1): 34-9. [Abstract] [Full-text]
57. Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia.
    Cancer Chemother Pharmacol, 57(1): 73-83. [Abstract] [Full-text]
58. Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy.
    Cancer Chemother Pharmacol, 57(1): 40-5. [Abstract] [Full-text]
59. Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer.
    Cancer Chemother Pharmacol, 57(1): 114-9. [Abstract] [Full-text]
60. Weekly docetaxel and zoledronic acid every 4 weeks in hormone-refractory prostate cancer patients.
    Cancer Chemother Pharmacol, 57(1): 46-51. [Abstract] [Full-text]
61. Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors.
    Cancer Chemother Pharmacol, 57(1): 15-24. [Abstract] [Full-text]
62. Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
    Cancer Chemother Pharmacol, 57(1): 59-64. [Abstract] [Full-text]
63. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Cancer Chemother Pharmacol, 57(1): 65-72. [Abstract] [Full-text]
64. Carotid artery stenting with neuroprotection: assessing the learning curve and treatment outcome.
    Am J Surg, 190(6): 850-7. [Abstract] [Full-text]
65. Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2.
    Clin Oral Implants Res, 16(6): 676-82. [Abstract] [Full-text]
66. Advances in chemotherapy for patients with extremity soft tissue sarcoma.
    Orthop Clin North Am, 37(1): 15-22. [Abstract] [Full-text]
67. Effect of postmenopause and hormone replacement therapy on serum adiponectin levels.
    Metabolism, 54(12): 1610-4. [Abstract] [Full-text]
68. Explanation for the survival benefit of primary angioplasty over thrombolytic therapy in patients with ST-elevation acute myocardial infarction.
    Am J Cardiol, 96(11): 1503-5. [Abstract] [Full-text]
69. Administration of intracoronary eptifibatide during ST-elevation myocardial infarction.
    Am J Cardiol, 96(11): 1494-7. [Abstract] [Full-text]
70. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).
    Am J Cardiol, 96(11): 1469-75. [Abstract] [Full-text]
71. Radiochemotherapy with Vinblastine, Methotrexate, and Bleomycin in the treatment of verrucous carcinoma of the head and neck.
    J Surg Oncol, 92(4): 278-83. [Abstract] [Full-text]
72. Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?
    Cancer Immunol Immunother, 55(2): 221-8. [Abstract] [Full-text]
73. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase.
    Eur J Haematol, 75(6): 518-21. [Abstract] [Full-text]
74. Inhibition of in-stent restenosis in rabbit iliac arteries with photodynamic therapy.
    Eur J Vasc Endovasc Surg, 30(6): 573-81. [Abstract] [Full-text]

© 2004-2008 Chemotherapy Research Today. All Rights Reserved.